Patents by Inventor Jolanta Lukasiewicz

Jolanta Lukasiewicz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MDR E. COLI IMMUNOGEN
    Publication number: 20230277643
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Application
    Filed: November 22, 2022
    Publication date: September 7, 2023
    Inventors: Eszter NAGY, Gábor NAGY, Valéria SZIJÁRTO, Zóltan MAGYARICS, Irina MIRKINA, Luis GAUCHALLA, Adriana BADARAU, Gerhild ZAUNER, Jolanta LUKASIEWICZ
  • MDR immunogen
    Patent number: 11529405
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: December 20, 2022
    Assignee: Janssen Pharmaceuticals, Inc.
    Inventors: Eszter Nagy, Gäbor Nagy, Valéria Szijárto, Zóltan Magyarics, Irina Mirkina, Luis Gauchalla, Adriana Badarau, Gerhild Zauner, Jolanta Lukasiewicz
  • MDR E. COLI SPECIFIC ANTIBODY
    Publication number: 20210162034
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Applicant: X4 PHARMACEUTICALS (AUSTRIA) GMBH
    Inventors: Eszter NAGY, Gábor NAGY, Valéria SZIJÁRTO, Zoltán MAGYARICS, Irina MIRKINA, Luis GUACHALLA, Adriana BADARAU, Gerhild ZAUNER, Jolanta LUKASIEWICZ
  • MDR specific antibody
    Patent number: 10940191
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: March 9, 2021
    Assignee: X4 PHARMACEUTICALS (AUSTRIA) GMBH
    Inventors: Eszter Nagy, Gábor Nagy, Valéria Szijárto, Zoltán Magyarics, Irina Mirkina, Luis Guachalla, Adriana Badarau, Gerhild Zauner, Jolanta Lukasiewicz
  • MDR E. COLI SPECIFIC ANTIBODY
    Publication number: 20190111121
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 18, 2019
    Applicant: ARSANIS BIOSCIENCES GMBH
    Inventors: Eszter NAGY, Gábor NAGY, Valéria SZIJÁRTO, Zoltán MAGYARICS, Irina MIRKINA, Luis GUACHALLA, Adriana BADARAU, Gerhild ZAUNER, Jolanta LUKASIEWICZ
  • MDR specific antibody
    Patent number: 10206992
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: February 19, 2019
    Assignee: ARSANIS BIOSCIENCES GMBH
    Inventors: Eszter Nagy, Gábor Nagy, Valéria Szijárto, Zoltán Magyarics, Irina Mirkina, Luis Guachalla, Adriana Badarau, Gerhild Zauner, Jolanta Lukasiewicz
  • MDR specific antibody
    Patent number: 9849169
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: December 26, 2017
    Assignee: ARSANIS Biosciences GmbH
    Inventors: Eszter Nagy, Gábor Nagy, Valéria Szijárto, Zoltán Magyarics, Irina Mirkina, Luis Guachalla, Adriana Badarau, Gerhild Zauner, Jolanta Lukasiewicz
  • MDR E. COLI SPECIFIC ANTIBODY
    Publication number: 20170087236
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Application
    Filed: December 9, 2016
    Publication date: March 30, 2017
    Applicant: ARSANIS BIOSCIENCES GMBH
    Inventors: Eszter NAGY, Gábor NAGY, Valéria SZIJÁRTO, Zoltán MAGYARICS, Irina MIRKINA, Luis GUACHALLA, Adriana BADARAU, Gerhild ZAUNER, Jolanta LUKASIEWICZ
  • Polysaccharide and derivatives thereof, showing affinity to ficolin-3, method of preparation and use
    Patent number: 9382338
    Abstract: The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from Hafnia alvei lipopolysaccharides, as well as conjugates of these polysaccharides with carriers and methods for their preparation and methods to use of these substances as ligands for human ficolin-3.
    Type: Grant
    Filed: June 11, 2011
    Date of Patent: July 5, 2016
    Assignees: INSTYTUT BIOLOGII MEDYCZNEJ POLSKIEJ AKADEMII NAUK, INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ PAN
    Inventors: Jolanta Lukasiewicz, Anna Swierzko, Maciej Cedzynski, Czeslaw Lugowski, Anna Maciejewska, Wojciech Jachymek, Tomasz Niedziela
  • AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
    Publication number: 20160136285
    Abstract: The subject of the present invention is an isolated antigen being an immunogenic form of the common enterobacterial antigen (ECA) of Gram-negative bacteria of the family Enterobacteriaceae: ECA combined with lipopolysaccharide (ECALPS); a glycoconjugate of inactivated form of this antigen with a protein, as well as compositions and vaccines containing such an antigen/glycoconjugate designed for the prevention and treatment infections caused by Gram-negative bacteria.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 19, 2016
    Applicant: WROCLAWSKIE CENTRUM BADAN EIT+ SP. Z O.O.
    Inventors: Tomasz GOZDZIEWICZ, Jolanta LUKASIEWICZ, Czeslaw LUGOWSKI
  • MDR E. COLI SPECIFIC ANTIBODY
    Publication number: 20150322138
    Abstract: The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
    Type: Application
    Filed: January 17, 2014
    Publication date: November 12, 2015
    Inventors: Eszter NAGY, Gábor NAGY, Valéria SZIJÁRTO, Zoltán MAGYARICS, Irina MIRKINA, Luis GUACHALLA, Adriana BADARAU, Gerhild ZAUNER, Jolanta LUKASIEWICZ
  • POLYSACCHARIDE AND DERIVATIVES THEREOF, SHOWING AFFINITY TO FICOLIN-3, METHOD OF PREPARATION AND USE
    Publication number: 20130266971
    Abstract: The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from Hafnia alvei lipopolysaccharides, as well as conjugates of these polysaccharides with carriers and methods for their preparation and methods to use of these substances as ligands for human ficolin-3.
    Type: Application
    Filed: June 11, 2011
    Publication date: October 10, 2013
    Applicants: INSTYTUT BIOLOGII MEDYCZNEJ POLSKIEJ AKADEMII NAUK, INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ PAN
    Inventors: Jolanta Lukasiewicz, Anna Swierzko, Maciej Cedzynski, Czeslaw Lugowski, Anna Maciejewska, Wojciech Jachymek, Tomasz Niedziela